Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

Item
http://www.wikidata.org/entity/Q33417461
Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.Common variable immunodeficiency, immune thrombocytopenia, rituximab and splenectomy: important considerations.State of the art - how I manage immune thrombocytopenia.Immunoglobulin replacement therapy in secondary hypogammaglobulinemiaAntibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia.Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.False Negative Toxoplasma Serology in an Immunocompromised Patient with PCR Positive Ocular Toxoplasmosis.Subcutaneous immunoglobulins for the treatment of a patient with antisynthetase syndrome and secondary chronic immunodeficiency after anti-CD20 treatment: a case report.Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.Abatacept as a Therapeutic Option for Rheumatoid Vasculitis.Therapeutic Management of Pediatric Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
P2860

Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

Item
http://www.wikidata.org/entity/Q33417461
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Profound symptomatic hypogamma ...... atic review of the literature.
@ast
Profound symptomatic hypogamma ...... atic review of the literature.
@en
type
label
Profound symptomatic hypogamma ...... atic review of the literature.
@ast
Profound symptomatic hypogamma ...... atic review of the literature.
@en
prefLabel
Profound symptomatic hypogamma ...... atic review of the literature.
@ast
Profound symptomatic hypogamma ...... atic review of the literature.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Profound symptomatic hypogamma ...... atic review of the literature.
@en
P2093
P304
P31
P356
10.1016/J.AUTREV.2014.08.036
P433
P478
P50
P577
P698
P921